CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 34 enrolled
Drug / intervention
DAPPERbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04091347
NCT04091347N/ACompleted
CompareCT.gov

Pilot Study of Depression and Pain Perseverance Through Empowered Recovery (DAPPER) Intervention

Johns Hopkins University·interventional·Posted Sep 16, 2019·Updated Nov 19, 2025

In Brief

A clinical study evaluating DAPPER for Pain and 3 related conditions. Completed, enrolled 34 participants across 1 site.

Detailed Summary

African American women who are 50 years of age and older with depressive symptoms, pain and difficulty with mobility will participate in the DAPPER intervention study that includes 8 nurse visits in participants' homes to help participants with participants' pain and mood.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPain, Depressive Symptoms, Frailty, Aging
CountriesUnited States
CollaboratorsRobert Wood Johnson Foundation, National Institute on Aging (NIA)

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedSep 16, 2019
Enrollment StartJan 2, 2020
Primary CompletionNov 30, 2023
TodayJul 2, 2026
Enrollment to primary: 3.9 yearsPosted 6.8 years ago

Interventions

DAPPERbehavioral

The DAPPER program is person directed and will consist of 8 nurse visits during which the nurse assesses each participant for pain, depression and frailty and then implements a manualized individually tailored intervention. Participants will be randomized into either the intervention or the wait list control group. Once the intervention group has completed the intervention group's visits, the wait list control group will begin the waitlist control group's visits. All participants will all be offered the same information and format of nurse visits. The nurses will systematically tailor the content of the visits to the participants' risk profile and goals based on protocols. All participants will be assessed at the start of the study, at 12 weeks and 24 weeks.